Page History

If your trial is Complete, follow the instructions in Registering New Complete Trials.

• Cancer Center trials must meet the following criteria to be eligible for registration:

  • Trials must have been active as of January 1, 2009 or any time thereafter. 

  • Submitting organization is the Lead Organization or the Coordinating Center.

• CTEP or DCP PIO-managed trials must meet the following criteria to be eligible for registration:

  • If NCI-managed, trials must have been active as of January 1, 2009 or any time thereafter.

  • If NCI-sponsored, trials must have been still open (not yet Completed) as of December 26, 2007 or opened anytime thereafter.

    Note
    Cancer Centers do not register PIO-managed trials or NCI-CCR trials. PIO-managed trials are submitted to CTRP directly by CTEP and DCP. NCI-CCR trials are managed in ClinicalTrials.gov by CCR.

• NCT ID (which indicates that the trial has been registered with ClinicalTrials.gov)

• Cancer Center type (NCI-designated Cancer Centers or other centers)

• NCI grant

• Lead organization

Guidelines for Trials with NCT IDs

If the trial is an Industry funded trial, and has an NCT ID, then it can be imported into CTRP from ClinicalTrials.gov in most cases. In some special cases, however, the trial cannot be imported directly and instead you must contact the CTRO for assistance.

• If your organization is not an NCI-designated Cancer Center organization, NIH institute, or pharmaceutical company, you will need to import the trial directly from ClinicalTrials.gov. For instructions on this process, refer to Registering Abbreviated (Industrial and Other) Trials. 

• If your organization is the Lead Organization on a trial, and your organization is an NCI-designated Cancer Center organization, do not import the trial from ClinicalTrials.gov. Instead, submit the trial to CTRP as a Complete trial. For instructions, refer to Registering New Complete Trials.

• If your organization is the Lead Organization for any trial on anything other than an NCI-designated Cancer Center organization, NIH institute, or pharmaceutical company trial, the CTRO contacts the Center and further categorizes the trial as Other/National or Other/Externally Peer-Reviewed based on whether your trial is conducted under an NIH grant, as follows:

  • If your trial is conducted under an NCI grant, the CTRO categorizes it as a Consortia trial.

  • If your trial is not conducted under an NCI grant, the CTRO categorizes it as follows:

    • Other/National, for trials sponsored by an NIH institute

    • Other/Externally Peer-Reviewed, for trials managed by a hospital or a center other than one designated by the NCI